» Articles » PMID: 11843096

Iron and Parkinson's Disease

Overview
Journal Neuroscientist
Publisher Sage Publications
Specialty Neurology
Date 2002 Feb 15
PMID 11843096
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple studies implicate iron in the pathophysiology of Parkinson's disease (PD). In the brains of patients with PD, iron levels are elevated and the levels of iron-binding proteins are abnormal. Iron has been suspected to contribute to PD because Fe(II) is known to promote oxidative damage. Recent studies suggest that an additional mechanism by which iron might contribute to PD is by inducing aggregation of the alpha-synuclein, which is a protein that accumulates in Lewy bodies in PD.

Citing Articles

Shared interactions of six neurotropic viruses with 38 human proteins: a computational and literature-based exploration of viral interactions and hijacking of human proteins in neuropsychiatric disorders.

Ozer E, Keskin A, Berrak Y, Cankara F, Can F, Gursoy-Ozdemir Y Discov Ment Health. 2025; 5(1):18.

PMID: 39987419 PMC: 11846830. DOI: 10.1007/s44192-025-00128-2.


The Interplay between Intracellular Iron Homeostasis and Neuroinflammation in Neurodegenerative Diseases.

Lee J, Hyun D Antioxidants (Basel). 2023; 12(4).

PMID: 37107292 PMC: 10135822. DOI: 10.3390/antiox12040918.


Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson's Disease: What We Know so Far.

Sivagurunathan N, Gnanasekaran P, Calivarathan L Degener Neurol Neuromuscul Dis. 2023; 13:1-13.

PMID: 36726995 PMC: 9885882. DOI: 10.2147/DNND.S361526.


Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.

Yang L, Cheng Y, Sun Y, Xuan Y, Niu J, Guan J Front Aging Neurosci. 2022; 14:792778.

PMID: 35370619 PMC: 8965454. DOI: 10.3389/fnagi.2022.792778.


Elucidating the Interaction of Human Ferritin with Quercetin and Naringenin: Implication of Natural Products in Neurodegenerative Diseases: Molecular Docking and Dynamics Simulation Insight.

Shamsi A, Shahwan M, Khan M, Husain F, Alhumaydhi F, Aljohani A ACS Omega. 2021; 6(11):7922-7930.

PMID: 33778303 PMC: 7992174. DOI: 10.1021/acsomega.1c00527.